About the Role
Flax Health is seeking a Lead Machine Learning Researcher / Applied Scientist to drive our most ambitious AI research and development efforts. This is a unique opportunity to shape the foundational ML breakthroughs that power our production systems. You’ll explore and define new approaches in document understanding, clinical data extraction, multi-modal modeling, and agentic systems—all while working in a high-autonomy, resource-rich environment.
Your work won’t live in an academic silo. At Flax, our research is product-critical: the models you develop and benchmark get deployed directly into our automated workflows, affecting clinical quality, financial performance, and operational efficiency for skilled nursing facilities across the country.
We’re looking for someone entrepreneurial and rigorous—equally comfortable writing novel methods and launching scalable evaluations. If you're energized by publishing research and shipping impactful systems, we’d love to hear from you.
What we offer:
An opportunity to lead and shape research from the ground up, with the resources of a well-funded startup (backed by Sorenson Capital and Pear VC), cutting-edge infrastructure, and a world-class engineering team ready to bring ideas to life.
Access to rich, real-world healthcare data, enabling applied research with direct, measurable impact on patient care and clinical operations.
A foundational role in establishing Flax’s applied research culture, with a clear path toward technical leadership and team-building as the organization scales.
True autonomy to chart research direction, influence product decisions, and define the frontier of what’s possible in healthcare ML, from models to deployment.
About the Company
Flax Health is on a mission to modernize operations for post-acute care. Our AI-powered platform extracts structured insights from complex clinical documentation to automate critical workflows such as case selection, patient intake, and claims appeals—helping operators boost reimbursement rates, reduce administrative burden, and accelerate cash flow.
We are backed by leading investors Sorenson Capital and Pear VC, and we’re currently rolling out our first product to customers. At Flax, we’re building for impact, with a sharp focus on reducing clinician burden, enabling better financial outcomes, and transforming how post-acute care is delivered.